Log in

Relevant bibliographies by topics / Vasopressor / Journal articles

To see the other types of publications on this topic, follow the link: Vasopressor.

Journal articles on the topic 'Vasopressor'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Vasopressor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Guinot, Pierre-Grégoire, Audrey Martin, Vivien Berthoud, et al. "Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition." Journal of Clinical Medicine 10, no. 14 (2021): 3164. http://dx.doi.org/10.3390/jcm10143164.

Full text

Abstract:

Despite the abundant literature on vasopressor therapy, few studies have focused on vasopressor-sparing strategies in patients with shock. We performed a scoping-review of the published studies evaluating vasopressor-sparing strategies by analyzing the results from randomized controlled trials conducted in patients with shock, with a focus on vasopressor doses and/or duration reduction. We analyzed 143 studies, mainly performed in septic shock. Our analysis demonstrated that several pharmacological and non-pharmacological strategies are associated with a decrease in the duration of vasopressor

APA, Harvard, Vancouver, ISO, and other styles

2

Van Haren, Robert M., Chad M. Thorson, Evan J. Valle, et al. "Vasopressor Use during Emergency Trauma Surgery." American Surgeon 80, no. 5 (2014): 472–78. http://dx.doi.org/10.1177/000313481408000518.

Full text

Abstract:

Most evidence suggests early vasopressor use is associated with death after trauma, but no previous study has focused on patients requiring emergency operative intervention (OR). We test the hypothesis that vasopressors are harmful in this population. Records from 746 patients requiring OR from July 2009 to March 2013 were retrospectively reviewed and stratified based on vasopressor use (epinephrine [EPI], phenylephrine, ephedrine, norepinephrine, dobutamine, vasopressin) or no vasopressor use. Vasopressors were administered to 225 patients (30%) during OR; 59 patients (8%) received multiple v

APA, Harvard, Vancouver, ISO, and other styles

3

Hamzaoui, Olfa, Antoine Goury, and Jean-Louis Teboul. "The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock." Journal of Clinical Medicine 12, no. 14 (2023): 4589. http://dx.doi.org/10.3390/jcm12144589.

Full text

Abstract:

Septic shock is mainly characterized—in addition to hypovolemia—by vasoplegia as a consequence of a release of inflammatory mediators. Systemic vasodilatation due to depressed vascular tone results in arterial hypotension, which induces or worsens organ hypoperfusion. Accordingly, vasopressor therapy is mandatory to correct hypotension and to reverse organ perfusion due to hypotension. Currently, two vasopressors are recommended to be used, norepinephrine and vasopressin. Norepinephrine, an α1-agonist agent, is the first-line vasopressor. Vasopressin is suggested to be added to norepinephrine

APA, Harvard, Vancouver, ISO, and other styles

4

Knotzer, Hans, Bernhard Poidinger, and Axel Kleinsasser. "Pharmacologic Agents for the Treatment of Vasodilatory Shock." Current Pharmaceutical Design 25, no. 19 (2019): 2133–39. http://dx.doi.org/10.2174/1381612825666190704101907.

Full text

Abstract:

: Vasodilatory shock is a life-threatening syndrome in critically ill patients and is characterized by severe hypotension and resultant tissue hypoperfusion. This shock state requires the use of vasopressor agents to restore adequate vascular tone. : Norepinephrine is still recommended as first-line vasopressor in the management of critically ill patients suffering from severe vasodilation. In the recent time, catecholaminergic vasopressor drugs have been associated with possible side effects at higher dosages. This so-called catecholamine toxicity has focused on alternative noncatecholaminerg

APA, Harvard, Vancouver, ISO, and other styles

5

Bissell, Brittany D., Carolyn Magee, Peter Moran, Melissa L. Thompson Bastin, and Alexander H. Flannery. "Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock." Journal of Intensive Care Medicine 34, no. 9 (2017): 761–65. http://dx.doi.org/10.1177/0885066617716396.

Full text

Abstract:

Rationale: Vasopressors such as norepinephrine are first line for support of mean arterial pressure (MAP) in the management of septic shock. Their use, however, is commonly associated with many adverse events. These detriments frequently trigger the use of alternative, noncatecholamine therapies, including vasopressin. Vasopressin deficiency is a known physiologic consequence of septic shock, and while guidelines recommend vasopressin in addition to norepinephrine, no consensus exists on the duration of deficiency or ideal time of cessation. Studies have suggested that vasopressin discontinuat

APA, Harvard, Vancouver, ISO, and other styles

6

Ramesh, Ambika, Akshith Doddi, Aisha Abbasi, Mohammad A. Al-Mamun, Ankit Sakhuja, and Khaled Shawwa. "Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy." PLOS ONE 19, no. 12 (2024): e0315643. https://doi.org/10.1371/journal.pone.0315643.

Full text

Abstract:

Objective To investigate whether the use of a specific vasopressor was associated with increased mortality or adverse outcomes in patients with acute kidney injury (AKI) receiving continuous kidney replacement therapy (CKRT). Methods Patients with AKI who underwent CKRT between 1/1/2012-1/1/2021 at a tertiary academic hospital were included. Cox proportional hazard model was used to assess the relationship between time-dependent vasopressor dose and in-hospital mortality. Results There were 641 patients with AKI that required CKRT. In-hospital mortality occurred in 318 (49.6%) patients. Those

APA, Harvard, Vancouver, ISO, and other styles

7

Gao, Hans, Samuel Garcia, Aidan Mullan, Daniel Fiterman Molinari, and Aaron Klassen. "From Ambulance to Admission." International Journal of Paramedicine, no. 10 (April 16, 2025): 37–54. https://doi.org/10.56068/ipna1247.

Full text

Abstract:

OBJECTIVE: Vasopressors are critical for patients experiencing shock. This observational study aims to describe the usage of vasopressors by EMS, and to assess how vasopressor usage differs between transport and hospital environments. The information gathered in this study can help determine which vasopressors should be available in an EMS system and guide the management of patients requiring vasopressors during EMS transport. METHODS: A retrospective observation study was performed from December 2019 to December 2022. Inclusion criteria were adult patients who received vasopressor infusions d

APA, Harvard, Vancouver, ISO, and other styles

8

McHargue, Cody, Tam Pham, Julie Rizzo, and James Aden. "89 Vasopressor Use and Burn Resuscitation Outcomes at 5 Major US Burn Centers." Journal of Burn Care & Research 46, Supplement_1 (2025): S72. https://doi.org/10.1093/jbcr/iraf019.089.

Full text

Abstract:

Abstract Introduction Prior research indicates that vasopressors are sometimes used during acute burn resuscitation, though significant concerns exist due to vasoconstrictive effects, reduced organ perfusion, and risks of organ failure and death. The purpose of this study was to examine the use of vasopressor infusions (to include epinephrine, norepinephrine, dopamine and vasopressin) during acute burn resuscitation in five major burn centers across the United States. Methods This was a secondary analysis of the Burn Navigator (BN) study, a multicenter observational trial that enrolled 300 pat

APA, Harvard, Vancouver, ISO, and other styles

9

Edward Gultom, Andrio Farel, Rommy F. Nadeak, Tasrif Hamdi, and Yuki Yunanda. "Perbandingan Vasopressin dan Norephinephrine sebagai Vasopressor pada Pasien Syok Sepsis." Jurnal Anestesi Perioperatif 12, no. 2 (2024): 97–108. http://dx.doi.org/10.15851/jap.v12n2.3739.

Full text

Abstract:

Sepsis menyebabkan kematian terbesar, tingkat mortalitas sepsis tinggi dan dapat mencapai 50% pada syok sepsis. Tatalaksana resusitasi pada syok sepsis menggunakan vasopresor. norepinephrine saat ini adalah rekomendasi utama pada syok sepsis, vasopressin digunakan sebagai obat lini kedua untuk mengurangi efek samping yang disebabkan oleh obat seperti norephinephrine, dan juga membantu pada keadaan syok resisten-katekolamin. Penelitian ini merupakan penelitian uji klinis dengan metode acak tersamar ganda. Penelitian ini bertujuan untuk mengetahui perbandingan penggunaan vasopressin dan norephin

APA, Harvard, Vancouver, ISO, and other styles

10

Patel, Bhavesh M., Dean R. Chittock, James A. Russell, and Keith R. Walley. "Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock." Anesthesiology 96, no. 3 (2002): 576–82. http://dx.doi.org/10.1097/00000542-200203000-00011.

Full text

Abstract:

Background Septic shock is associated with vasopressin deficiency and a hypersensitivity to its exogenous administration. The goal of the current study was to determine whether short-term vasopressin infusion in patients experiencing severe septic shock has a vasopressor sparing effect while maintaining hemodynamic stability and adequate end-organ perfusion. Methods Patients experiencing septic shock that required high-dose vasopressor support were randomized to a double-blinded 4-h infusion of either norepinephrine (n = 11) or vasopressin (n = 13), and open-label vasopressors were titrated to

APA, Harvard, Vancouver, ISO, and other styles

11

Karami, Mina, Veemal V. Hemradj, Dagmar M. Ouweneel, et al. "Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis." Journal of Clinical Medicine 9, no. 7 (2020): 2051. http://dx.doi.org/10.3390/jcm9072051.

Full text

Abstract:

Vasopressors and inotropes are routinely used in acute myocardial infarction (AMI) related cardiogenic shock (CS) to improve hemodynamics. We aimed to investigate the effect of routinely used vasopressor and inotropes on mortality in AMI related CS. A systematic search of MEDLINE, EMBASE and CENTRAL was performed up to 20 February 2019. Randomized and observational studies reporting mortality of AMI related CS patients were included. At least one group should have received the vasopressor/inotrope compared with a control group not exposed to the vasopressor/inotrope. Exclusion criteria were ca

APA, Harvard, Vancouver, ISO, and other styles

12

Nelakuditi, Manikanta, and Shilpa Bawankule. "Evaluating the impact of early vs. late vasopressor use on outcomes in sepsis patients: A systematic review." Multidisciplinary Reviews 8, no. 8 (2025): 2025249. https://doi.org/10.31893/multirev.2025249.

Full text

Abstract:

Sepsis is a leading cause of morbidity and mortality in critically ill patients, with timely intervention being crucial to improving outcomes. The use of vasopressors, particularly norepinephrine, plays a vital role in managing sepsis-induced hypotension, but the optimal timing of vasopressor initiation remains debated. Early initiation may improve outcomes by stabilising hemodynamics sooner, while delayed use could allow for more aggressive fluid resuscitation. To systematically review the evidence on the impact of early versus late vasopressor initiation on clinical outcomes in patients with

APA, Harvard, Vancouver, ISO, and other styles

13

Goldsmith, Steven R. "Vasopressin as vasopressor." American Journal of Medicine 82, no. 6 (1987): 1213–19. http://dx.doi.org/10.1016/0002-9343(87)90228-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Claes, B., G. Eerdekens, and L. Al Tmimi. "Insights into haemorrhagic shock: A narrative review of pathophysiology and vasopressor options." Acta Anaesthesiologica Belgica 75, Supplement 1 (2024): 195–202. https://doi.org/10.56126/76.s1.19.

Full text

Abstract:

Haemorrhagic shock is a critical condition characterised by decreased circulating blood volume due to significant fluid or blood loss, resulting in impaired tissue perfusion and oxygen delivery. The management of haemorrhagic shock requires an understanding of its complex pathophysiology and the implementation of appropriate treatment strategies. This review focuses on the role of vasopressors in the management of haemorrhagic shock, addressing the current understanding of its pathophysiology and the use of vasopressors. The review evaluates the use of different vasopressors, including norepin

APA, Harvard, Vancouver, ISO, and other styles

15

Ahmed Ali, Ahmed Talaat, Mervat Anwar Abd EL-Aziz, Ahmed Mohamed Abdelhafez, and Amr Mohamed Ahmed Thabet. "Effect of Oral Vasopressors Used for Liberation from Intravenous Vasopressors in Intensive Care Unit Patients Recovering from Spinal Shock: A Randomized Controlled Trial." Critical Care Research and Practice 2022 (January 18, 2022): 1–6. http://dx.doi.org/10.1155/2022/6448504.

Full text

Abstract:

Background. Early vasopressor utilization has been associated with improved outcomes of patients with spinal shock; however, there are difficulties in weaning off vasopressors, in which patients after recovery from spinal shock develop a state of persistent vasodilation, which may take a few days to resolve and delays the discharge in the intensive care unit (ICU). Therefore, we tested the hypothesis using two oral vasopressors (midodrine and minirin) to facilitate weaning off intravenous vasopressors, reducing the ICU length of stay, and compare them for more efficacy. Methods. A randomized c

APA, Harvard, Vancouver, ISO, and other styles

16

Costa, Deena Kelly, Hannah C. Ratliff, Meghan Kelly, et al. "Extubation of Patients Receiving Vasopressor Infusions: Results of a Survey on Statewide Practices." American Journal of Critical Care 32, no. 2 (2023): 127–30. http://dx.doi.org/10.4037/ajcc2023489.

Full text

Abstract:

Current guidelines recommend extubation only if a patient is not receiving vasopressor therapy or is receiving minimal doses of vasopressors. However, recent data indicate that extubation of patients receiving higher vasopressor doses may be safe. This study was undertaken to examine practices regarding extubation of patients receiving vasopressor therapy reported by clinician respondents to a survey by the Michigan Health and Hospital Association Keystone Center. One-third of respondents indicated that they would extubate a patient receiving vasopressors, and one-quarter indicated that it dep

APA, Harvard, Vancouver, ISO, and other styles

17

García-Álvarez, Raquel, and Rafael Arboleda-Salazar. "Vasopressin in Sepsis and Other Shock States: State of the Art." Journal of Personalized Medicine 13, no. 11 (2023): 1548. http://dx.doi.org/10.3390/jpm13111548.

Full text

Abstract:

This review of the use of vasopressin aims to be comprehensive and highly practical, based on the available scientific evidence and our extensive clinical experience with the drug. It summarizes controversies about vasopressin use in septic shock and other vasodilatory states. Vasopressin is a natural hormone with powerful vasoconstrictive effects and is responsible for the regulation of plasma osmolality by maintaining fluid homeostasis. Septic shock is defined by the need for vasopressors to correct hypotension and lactic acidosis secondary to infection, with a high mortality rate. The Survi

APA, Harvard, Vancouver, ISO, and other styles

18

Möller Petrun, Andreja, and Andrej Markota. "Angiotensin II—Real-Life Use and Literature Review." Medicina 60, no. 9 (2024): 1483. http://dx.doi.org/10.3390/medicina60091483.

Full text

Abstract:

Angiotensin II is a recently introduced vasopressor, which has been available since 2017. The novelty and the relatively high cost of angiotensin II currently limit its broader application. It induces vasoconstriction by activating the renin–angiotensin–aldosterone system and is currently the sole vasopressor functioning through this pathway. Beyond vasoconstriction, angiotensin II also affects various other physiological processes. Current evidence supports its use in managing vasoplegic and cardiogenic shock in patients who are unresponsive to catecholamines and vasopressin. However, due to

APA, Harvard, Vancouver, ISO, and other styles

19

Febrinasari, Ratih Puspita, Kenneth Tan, Astrida Fesky Febrianty, and Yusuf Ari Mashuri. "Effectiveness of Norepinephrine-Vasopressin Combination in Reducing Mortality in Septic Shock Patients: A Scoping Review." JPSCR: Journal of Pharmaceutical Science and Clinical Research 7, no. 1 (2022): 48. http://dx.doi.org/10.20961/jpscr.v7i1.54626.

Full text

Abstract:

Sepsis and septic shock are the major health problems worldwide, including in Indonesia. Sepsis and septic shock are medical emergencies that require adequate prompt resuscitation to reverse tissue hypo-perfusion, which will prevent patient mortality. The latest international guideline on septic shock treatment recommended norepinephrine as a first-line vasopressor followed by dopamine and dobutamine as an alternative vasopressor. However, the practices still vary. Therefore, a scoping review is required to scope the existing article, summarize scientific evidence, and give a bearing on future

APA, Harvard, Vancouver, ISO, and other styles

20

DeMott, Joshua M., Gourang Patel, and Ishaq Lat. "Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock." Annals of Pharmacotherapy 52, no. 1 (2017): 40–47. http://dx.doi.org/10.1177/1060028017726552.

Full text

Abstract:

Background: In septic shock, chronic antihypertensive medications are held acutely. Vasopressors are often required to maintain blood pressure. The effect of chronic exposure to antihypertensive therapies on vasopressor dosing in septic shock is not known. Objective: To determine the effects of chronic exposure to antihypertensive therapies, specifically β-blockers and angiotensin-converting enzyme (ACE) inhibitors, on cumulative vasopressor dosing in septic shock. Methods: This was a retrospective cohort review, with data collected from routine care. Patients admitted to the medical intensive

APA, Harvard, Vancouver, ISO, and other styles

21

Rizka Pratama, Agung, and Muhammad Fadil. "Peranan Inotropik dan Vasopresor dalam Terapi Syok Kardiogenik." Cermin Dunia Kedokteran 48, no. 6 (2021): 307. http://dx.doi.org/10.55175/cdk.v48i6.1430.

Full text

Abstract:

<p>Syok kardiogenik merupakan keadaan darurat medis yang mengancam jiwa dengan terjadinya hipoperfusi jaringan akibat berkurangnya curah jantung. Penyebab utama syok kardiogenik yaitu infark miokard akut dengan angka mortalitas mencapai 50%. Inotropik dan vasopresor telah menjadi landasan untuk stabilisasi gangguan hemodinamik dan curah jantung pada syok kardiogenik. Beberapa penelitian dan rekomendasi terbaru mengajukan dobutamin sebagai agen inotropik dan norepinefrin dibandingkan dopamin sebagai vasopressor lini pertama untuk tatalaksana syok kardiogenik.</p><p>Cardiogenic

APA, Harvard, Vancouver, ISO, and other styles

22

Hylands, Mathieu, Augustin Toma, Nicolas Beaudoin, et al. "Early vasopressor use following traumatic injury: a systematic review." BMJ Open 7, no. 11 (2017): e017559. http://dx.doi.org/10.1136/bmjopen-2017-017559.

Full text

Abstract:

ObjectivesCurrent guidelines suggest limiting the use of vasopressors following traumatic injury; however, wide variations in practice exist. Although excessive vasoconstriction may be harmful, these agents may help reduce administration of potentially harmful resuscitation fluids. This systematic review aims to compare early vasopressor use to standard resuscitation in adults with trauma-induced shock.DesignSystematic review.Data sourcesWe searched MEDLINE, EMBASE, ClinicalTrials.gov and the Central Register of Controlled Trials from inception until October 2016, as well as the proceedings of

APA, Harvard, Vancouver, ISO, and other styles

23

Atmodiwirjo, Parintosa, Mohamad Rachadian Ramadan, Michael Djohan, and Nadira Fildza Amanda. "Flaps or flat: a case report of double free flap survival after a prolonged cardiac arrest." Medical Journal of Indonesia 33, no. 2 (2024): 128–32. http://dx.doi.org/10.13181/mji.cr.247422.

Full text

Abstract:

This case addressed patient and free flap survival after cardiac arrest with the contentious use of vasopressors amid concerns about potential vasoconstrictive effects on flap vitality. A 59-year-old male with mucoepidermoid carcinoma underwent post-total maxillectomy and double free flap reconstruction (free fibular flap and anterolateral thigh free flap). Intraoperatively, he experienced cardiac arrest after anastomosis due to hypovolemia or hypoxia, requiring external cardiac massage and vasopressor administration. Despite the initial restoration of circulation, subsequent cardiac arrest en

APA, Harvard, Vancouver, ISO, and other styles

24

Gupta, Lalit, Vikash Bansal, Ripon Choudhary, and Ridhima Sharma. "Role and efficacy of vasopressors in post-spinal hypotension in cesarean section. Is norepinephrine a newer choice?" Indian Journal of Clinical Anaesthesia 11, no. 3 (2024): 414–20. http://dx.doi.org/10.18231/j.ijca.2024.075.

Full text

Abstract:

In elective cesarean section, spinal anesthesia-related hypotension is routinely prevented or treated with fluids and vasopressors. From the use of fluid preloading to co-loading and different vasopressors, Phenylephrine remains the vasopressor of choice in the management of hypotension during cesarean section under spinal anesthesia for a long time. However, in recent studies, Norepinephrine has also been found as effective as phenylephrine but its routine use has not been recommended till now for the same as a vasopressor agent, and among all the vasopressors, phenylephrine has emerged as th

APA, Harvard, Vancouver, ISO, and other styles

25

Shields, Beth A., Kaitlin A. Pruskowski, Alicia M. Williams, and Leopoldo C. Cancio. "708 Enteral Nutrition Initiation During Periods of Vasopressor Requirements and Elevated Lactate Levels." Journal of Burn Care & Research 41, Supplement_1 (2020): S185—S186. http://dx.doi.org/10.1093/jbcr/iraa024.294.

Full text

Abstract:

Abstract Introduction Nutrition is a core component of care for the critically ill burn patient. The Society for Critical Care Medicine recommends initiating enteral nutrition (EN) within 4–6 hours of injury for burn patients, while simultaneously recommending waiting until hemodynamic stability is achieved for critical care patients. The goal of this analysis was to evaluate tolerance of EN during periods of different pressor requirements and lactate levels. Methods We performed a retrospective evaluation on all burn patients admitted to our intensive care unit in 2018 who received EN. This p

APA, Harvard, Vancouver, ISO, and other styles

26

Fuchita, Mikita, Jack Pattee, Derek W. Russell, et al. "Prophylactic Administration of Vasopressors Prior to Emergency Intubation in Critically Ill Patients: A Secondary Analysis of Two Multicenter Clinical Trials." Critical Care Explorations 5, no. 7 (2023): e0946. http://dx.doi.org/10.1097/cce.0000000000000946.

Full text

Abstract:

OBJECTIVE: Hypotension affects approximately 40% of critically ill patients undergoing emergency intubation and is associated with an increased risk of death. The objective of this study was to examine the association between prophylactic vasopressor administration and the incidence of peri-intubation hypotension and other clinical outcomes. DESIGN: A secondary analysis of two multicenter randomized clinical trials. The clinical effect of prophylactic vasopressor administration was estimated using a one-to-one propensity-matched cohort of patients with and without prophylactic vasopressors. SE

APA, Harvard, Vancouver, ISO, and other styles

27

Currigan, Dale A., Richard J. A. Hughes, Christine E. Wright, James A. Angus, and Paul F. Soeding. "Vasoconstrictor Responses to Vasopressor Agents in Human Pulmonary and Radial Arteries." Anesthesiology 121, no. 5 (2014): 930–36. http://dx.doi.org/10.1097/aln.0000000000000430.

Full text

Abstract:

Abstract Background: Vasopressor drugs, commonly used to treat systemic hypotension and maintain organ perfusion, may also induce regional vasoconstriction in specialized vascular beds such as the lung. An increase in pulmonary vascular tone may adversely affect patients with pulmonary hypertension or right heart failure. While sympathomimetics constrict pulmonary vessels, and vasopressin does not, a direct comparison between these drugs has not been made. This study investigated the effects of clinically used vasopressor agents on human isolated pulmonary and radial arteries. Methods: Isolate

APA, Harvard, Vancouver, ISO, and other styles

28

Djafar, Muhammad Irfan, Andi Salahuddin, and Syafruddin Gaus. "EFFECT OF CRYSTALLOID FLUID LOADING AND VASOPRESSOR PRE-TREATMENT ON THE TIME OF BLOOD PRESSURE DROP IN CESAREAN SECTION WITH SUBARACHNOID BLOCK." Jurnal Kesehatan 15, no. 1 (2022): 37–49. http://dx.doi.org/10.24252/kesehatan.v15i1.27761.

Full text

Abstract:

Caesarean section (SC) is the most frequently performed surgery in obstetrics. Subarachnoid block (SAB) and epidural block are the most widely used anesthetic techniques in CS surgery. Objectives To analyze the effect of loading crystalloid fluid and administration of vasopressors on the time of occurrence of a decrease in blood pressure in SC with SAB anesthesia. Method single-blind randomized controlled clinical trial consisting of 2 treatment groups, namely crystalloid fluid loading and vasopressor pre-treatment. The Results There was a significant difference in mean blood pressure between

APA, Harvard, Vancouver, ISO, and other styles

29

Zaki, Hany A., Mohamed Elgassim, Eman E. Shaban, et al. "A Systematic Review and Meta-Analysis of the Timing of Vasopressor Therapy in Patients with Septic Shock: Assessing Clinical Outcomes and Implication." F1000Research 13 (April 18, 2024): 289. http://dx.doi.org/10.12688/f1000research.144976.1.

Full text

Abstract:

Background Septic shock, is associated with a high mortality rate and increased expenses. Currently, the first-line therapy for septic shock entails administering resuscitation fluids followed by infusing vasopressors when the blood pressure goal is not achieved. The recommended first-line vasopressor is norepinephrine, followed by vasopressin, epinephrine, angiotensin II, and dopamine. There is still a controversy on when each vasopressor should be administered. Therefore, we conducted this review to determine the impact and implications of vasopressor timing in septic shock patients. Methods

APA, Harvard, Vancouver, ISO, and other styles

30

Ibrahim, Abdullahi, Gabriela McElligott, Taranjeet Rathore, Michael Tijerina, and Mustapha Miko Mohammed Abdullahi. "The Use of Vasopressors by Nurses and Physicians in Nigeria." International Journal of Critical Care 18, no. 2 (2024): 27–36. http://dx.doi.org/10.29173/ijcc74.

Full text

Abstract:

Background:Supporting hemodynamics using vasopressive agents is common in the treatment of critically ill patients. It is imperative that clinicians administer these agents safely and appropriately. Data related to the awareness, use, selection, and implications of vasopressor use in Nigerian hospitals is lacking from the current literature. Aim: To assess clinician knowledge and attitudes toward vasopressor use while examining the demographic characteristics of nurses and physicians using vasopressors in Nigerian Hospitals, and to identify barriers affecting early vasopressor use to treat sep

APA, Harvard, Vancouver, ISO, and other styles

31

Cahen, Viviane C., Yimei Li, Evanette Burrows, et al. "A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort." Blood 132, Supplement 1 (2018): 3597. http://dx.doi.org/10.1182/blood-2018-99-114235.

Full text

Abstract:

Abstract Infectious complications are major contributors to morbidity and mortality in children with leukemia; however, clinical trial reporting is incomplete (Miller 2016 J Clin Oncol). Using administrative data to identify SS events could improve estimates of incidence and clinical impact. However, accurate SS determination is challenging, and the 2005 International Pediatric Sepsis Consensus Conference (IPSCC) definition is often modified for individual studies. ICD-9 codes, assigned at discharge, do not permit precise timing estimates. We hypothesized PHIS resource utilization (RU) codes c

APA, Harvard, Vancouver, ISO, and other styles

32

Sualang, Julian Welly, Ivy Jesslyn, and Dennis Prakas. "Penggunaan Norepinefrin pada Fase Dini Terapi Syok Sepsis dengan Gagal Ginjal Akut." Jurnal Kedokteran Meditek 28, no. 1 (2022): 47–51. http://dx.doi.org/10.36452/jkdoktmeditek.v28i1.2219.

Full text

Abstract:

Laporan Kasus ini memberi gambaran penggunaan norepinephrine awal dalam penanganan syok sepsis. Studi kasus melaporkan pria 65 tahun dengan keluhan nyeri perut dan tidak buang air kecil sejak 1 malam sebelum keluhan. Pasien didiagnosis dengan syok sepsis disebabkan perforasi gaster. Infus Vasopressor diberikan bersama cairan kristaloid. Panduan Surviving Sepsis Campaign (SSC) tahun 2018 merekomendasi pemberian antibiotik spektrum luas, pemberian cairan kristaloid segera, pemberian vasopresor setelah resusitasi cairan. Umumnya, cairan intravena diberikan terlebih dahulu diikuti pemberian vasopr

APA, Harvard, Vancouver, ISO, and other styles

33

Bird, Cole, Sofie Hass, Ragan Verelst, et al. "868 Beyond Resuscitation: Early Vasopressor Use as an Indicator of Clinical Severity in Burn Care Outcomes." Journal of Burn Care & Research 46, Supplement_1 (2025): S305. https://doi.org/10.1093/jbcr/iraf019.399.

Full text

Abstract:

Abstract Introduction Vasopressors are often necessary to manage hypotension during early shock in critically ill burn patients. This study examines the early use of vasopressors—administered within the first 72 hours post-burn injury—and its use as an indicator for key clinical outcomes. Methods We performed a retrospective chart review of adult burn patients (≥18 years) admitted to a regional burn center between 2010 and 2023. Patients included in the study had burns covering ≥20% total body surface area (TBSA) and received vasopressors within 72 hours of burn injury and continued for at lea

APA, Harvard, Vancouver, ISO, and other styles

34

Ismail, Samina, Muhammad Sohaib, and Fatima Farrukh. "Management of spinal-induced hypotension for elective caesarean section: A survey of practices among anesthesiologists from a developing country." African Health Sciences 20, no. 4 (2020): 1918–26. http://dx.doi.org/10.4314/ahs.v20i4.50.

Full text

Abstract:

Background: In developing countries, more than half of the anesthesia-related maternal deaths are related to spinal hypo- tension. Objective: To explore the practices of management of spinal induced hypotension with respect to fluid and vasopressor administration among anesthesiologists from a developing country. Methods: After approval from institutional ethics committee, an online questionnaire was sent to anesthesiologists reg- istered with Pakistan Society of Anesthesiologists between July and August 2018 to determine management strategies for prevention and treatment of spinal

APA, Harvard, Vancouver, ISO, and other styles

35

Post, Emiel Hendrik, Fuhong Su, Cláudia Righy Shinotsuka, et al. "Renal autoregulation in experimental septic shock and its response to vasopressin and norepinephrine administration." Journal of Applied Physiology 125, no. 6 (2018): 1661–69. http://dx.doi.org/10.1152/japplphysiol.00783.2017.

Full text

Abstract:

Evidence suggests that septic shock patients with chronic arterial hypertension may benefit from resuscitation targeted to achieve higher blood pressure values than other patients, possibly as a result of altered renal autoregulation. The effects of different vasopressor agents on renal autoregulation may be important in this context. We investigated the effects of arginine vasopressin (AVP) and norepinephrine (NE) on renal autoregulation in ovine septic shock. Sepsis was induced by fecal peritonitis. When shock developed (decrease in mean arterial pressure to <65 mmHg and no fluid responsi

APA, Harvard, Vancouver, ISO, and other styles

36

Ruggiero, Margaret S. "Effects of Vasopressin in Septic Shock." AACN Advanced Critical Care 19, no. 3 (2008): 281–87. http://dx.doi.org/10.4037/15597768-2008-3006.

Full text

Abstract:

Septic shock continues to be one of the leading causes of death in the intensive care unit today. The confluence of many factors contributes to the deterioration of patients’ condition in septic shock. Increased levels of nitric oxide, in part, mediate the cardiovascular effects of septic shock. Nitric oxide is major mediator of vasodilation and hypotension as well as myocardial depression. It also contributes to decreased production and release of endogenous vasopressin. Vasopressin effects are actualized by stimulation of V1, V2, and V3 receptors located in various parts of the body. The res

APA, Harvard, Vancouver, ISO, and other styles

37

Vincent, Jean-Louis, and Filippo Annoni. "Vasopressor Therapy." Journal of Clinical Medicine 13, no. 23 (2024): 7372. https://doi.org/10.3390/jcm13237372.

Full text

Abstract:

Vasopressor therapy represents a key part of intensive care patient management, used to increase and maintain vascular tone and thus adequate tissue perfusion in patients with shock. Norepinephrine is the preferred first-line agent because of its reliable vasoconstrictor effects, with minimal impact on heart rate, and its mild inotropic effects, helping to maintain cardiac output. Whichever vasopressor is used, its effects on blood flow must be considered and excessive vasoconstriction avoided. Other vasoactive agents include vasopressin, which may be considered in vasodilatory states, and ang

APA, Harvard, Vancouver, ISO, and other styles

38

Wu, Mike, Marzyeh Ghassemi, Mengling Feng, Leo A. Celi, Peter Szolovits, and Finale Doshi-Velez. "Understanding vasopressor intervention and weaning: risk prediction in a public heterogeneous clinical time series database." Journal of the American Medical Informatics Association 24, no. 3 (2016): 488–95. http://dx.doi.org/10.1093/jamia/ocw138.

Full text

Abstract:

Background: The widespread adoption of electronic health records allows us to ask evidence-based questions about the need for and benefits of specific clinical interventions in critical-care settings across large populations. Objective: We investigated the prediction of vasopressor administration and weaning in the intensive care unit. Vasopressors are commonly used to control hypotension, and changes in timing and dosage can have a large impact on patient outcomes. Materials and Methods: We considered a cohort of 15 695 intensive care unit patients without orders for reduced care who were ali

APA, Harvard, Vancouver, ISO, and other styles

39

Paľa, Andrej, Julia Schick, Moritz Klein, et al. "The influence of nimodipine and vasopressors on outcome in patients with delayed cerebral ischemia after spontaneous subarachnoid hemorrhage." Journal of Neurosurgery 132, no. 4 (2020): 1096–104. http://dx.doi.org/10.3171/2018.11.jns182891.

Full text

Abstract:

OBJECTIVEDelayed cerebral ischemia (DCI) is a major factor contributing to the inferior outcome of patients with spontaneous subarachnoid hemorrhage (SAH). Nimodipine and induced hypertension using vasopressors are an integral part of standard therapy. Consequences of the opposite effect of nimodipine and vasopressors on blood pressure on patient outcome remain unclear. The authors report the detailed general characteristics and influence of nimodipine and vasopressors on outcome in patients with SAH.METHODSThe authors performed a 2-center, retrospective, clinical database analysis of 732 SAH

APA, Harvard, Vancouver, ISO, and other styles

40

Readdy, William J., William D. Whetstone, Adam R. Ferguson, et al. "Complications and outcomes of vasopressor usage in acute traumatic central cord syndrome." Journal of Neurosurgery: Spine 23, no. 5 (2015): 574–80. http://dx.doi.org/10.3171/2015.2.spine14746.

Full text

Abstract:

OBJECT The optimal mean arterial pressure (MAP) for spinal cord perfusion after trauma remains unclear. Although there are published data on MAP goals after spinal cord injury (SCI), the specific blood pressure management for acute traumatic central cord syndrome (ATCCS) and the implications of these interventions have yet to be elucidated. Additionally, the complications of specific vasopressors have not been fully explored in this injury condition. METHODS The present study is a retrospective cohort analysis of 34 patients with ATCCS who received any vasopressor to maintain blood pressure ab

APA, Harvard, Vancouver, ISO, and other styles

41

Haimovich, Adrian D., Ruoyi Jiang, Richard A. Taylor, and Justin B. Belsky. "Risk factor identification and predictive models for central line requirements for patients on vasopressors." Anaesthesia and Intensive Care 49, no. 4 (2021): 275–83. http://dx.doi.org/10.1177/0310057x211024258.

Full text

Abstract:

Vasopressors are ubiquitous in intensive care units. While central venous catheters are the preferred route of infusion, recent evidence suggests peripheral administration may be safe for short, single-agent courses. Here, we identify risk factors and develop a predictive model for patient central venous catheter requirement using the Medical Information Mart for Intensive Care, a single-centre dataset of patients admitted to an intensive care unit between 2008 and 2019. Using prior literature, a composite endpoint of prolonged single-agent courses (>24 hours) or multi-agent courses of any

APA, Harvard, Vancouver, ISO, and other styles

42

Patterson, Anthony, Annette M. Bourgault, and Brad R. Crawford. "Correction of Severe Hypotension by Oral Pseudoephedrine in a Patient With Idiopathic Autonomic Dysfunction." American Journal of Critical Care 17, no. 5 (2008): 484–81. http://dx.doi.org/10.4037/ajcc2008.17.5.484.

Full text

Abstract:

The purpose of this case study was to review the use of an oral α-adrenergic agent to correct severe vasopressor-dependent hypotension in a patient with idiopathic autonomic dysfunction. Autonomic dysfunction resulting in severe hypotension that requires intravenous vasopressors can present challenges in the treatment of critically ill patients. Most patients are weaned from intravenous vasopressor agents once severe sepsis has resolved. Because of worsening idiopathic autonomic dysfunction during recovery from sepsis, this 76-year-old woman required prolonged care in the intensive care unit.

APA, Harvard, Vancouver, ISO, and other styles

43

Watts, Stacey, Yogesh Apte, Thomas Holland, et al. "Randomised, controlled, feasibility trial comparing vasopressor infusion administered via peripheral cannula versus central venous catheter for critically ill adults: A study protocol." PLOS ONE 19, no. 5 (2024): e0295347. http://dx.doi.org/10.1371/journal.pone.0295347.

Full text

Abstract:

Background When clinicians need to administer a vasopressor infusion, they are faced with the choice of administration via either peripheral intravenous catheter (PIVC) or central venous catheter (CVC). Vasopressor infusions have traditionally been administered via central venous catheters (CVC) rather than Peripheral Intra Venous Catheters (PIVC), primarily due to concerns of extravasation and resultant tissue injury. This practice is not guided by contemporary randomised controlled trial (RCT) evidence. Observational data suggests safety of vasopressor infusion via PIVC. To address this evid

APA, Harvard, Vancouver, ISO, and other styles

44

Cox, Jill, and Sharon Roche. "Vasopressors and Development of Pressure Ulcers in Adult Critical Care Patients." American Journal of Critical Care 24, no. 6 (2015): 501–10. http://dx.doi.org/10.4037/ajcc2015123.

Full text

Abstract:

Background Vasopressors are lifesaving agents used to raise mean arterial pressure in critically ill patients in shock states. The pharmacodynamics of these agents suggest vasopressors may play a role in development of pressure ulcers; however, this aspect has been understudied. Objective To examine associations between type, dose, and duration of vasopressors (norepinephrine, epinephrine, vasopressin, phenylephrine, dopamine) and development of pressure ulcers in medical-surgical and cardiothoracic intensive care unit patients and to examine predictors of the development of pressure ulcers in

APA, Harvard, Vancouver, ISO, and other styles

45

Tan, Kenneth, Benedictus Benedictus, and Christopher William Purnomo. "Comparison Between Norepinephrine-Epinephrine and Norepinephrine-Vasopressin Effectiveness in Reducing Mortality in Septic Shock: A Systematic Review." Solo Journal of Anesthesi, Pain and Critical Care (SOJA) 3, no. 1 (2023): 9. http://dx.doi.org/10.20961/soja.v3i1.62121.

Full text

Abstract:

<div class="page" title="Page 1"><div class="layoutArea"><div class="column"><p> </p><p><strong>Background: </strong>Sepsis is a state of organ dysfunction caused by the immune system’s abnormal response to an infection. Septic shock is sepsis complicated by circulatory and metabolic abnormalities, oftentimes resulting in death. Prompt identification and treatment of septic shock is crucial for the survival of patients. The latest international guideline recommends the administration of norepinephrine as the first line vasopressor, with the addit

APA, Harvard, Vancouver, ISO, and other styles

46

Derry, Kendall H., Madeline C. Rocks, Paul Izard, Rebecca S. Nicholas, Philip M. Sommer, and Jacques H. Hacquebord. "Limb Necrosis in the Setting of Vasopressor Use." American Journal of Critical Care 33, no. 3 (2024): 226–33. http://dx.doi.org/10.4037/ajcc2024171.

Full text

Abstract:

Background It remains poorly understood why only some hemodynamically unstable patients who receive aggressive treatment with vasopressor medications develop limb necrosis. Objective To determine the incidence of limb necrosis and the factors associated with it following high-dose vasopressor therapy. Methods A retrospective case-control medical records review was performed of patients aged 18 to 89 years who received vasopressor therapy between 2012 and 2021 in a single academic medical center. The study population was stratified by the development of limb necrosis following vasopressor use.

APA, Harvard, Vancouver, ISO, and other styles

47

Szumita, Paul M., Christopher M. Enfanto, Bonnie Greenwood, and Michael E. Wechsler. "Vasopressin for vasopressor-dependent septic shock." American Journal of Health-System Pharmacy 62, no. 18 (2005): 1931–36. http://dx.doi.org/10.2146/ajhp040614.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Kwak, Gloria H., Rajapaksha W. M. A. Madushani, Lasith Adhikari, et al. "Septic Shock Requiring Three Vasopressors: Patient Demographics and Outcomes." Critical Care Explorations 6, no. 11 (2024): e1167. http://dx.doi.org/10.1097/cce.0000000000001167.

Full text

Abstract:

OBJECTIVES: Septic shock is a common condition necessitating timely management including hemodynamic support with vasopressors. Despite the high prevalence and mortality, there is limited data characterizing patients who require three or more vasopressors. We sought to define the demographics, outcomes, and prognostic determinants associated with septic shock requiring three or more vasopressors. DESIGN: This is a multicenter retrospective cohort of two ICU databases, Medical Information Mart for Intensive Care IV (MIMIC-IV) and electronic ICU-Clinical Research Database, which include over 400

APA, Harvard, Vancouver, ISO, and other styles

49

Tsai, Michelle, Jamie Benken, Joshua Adisumarta, et al. "Comparison of Angiotensin II (Giapreza®) Use in Kidney Transplantation Between Black and Non-Black Patients." Biomedicines 13, no. 8 (2025): 1819. https://doi.org/10.3390/biomedicines13081819.

Full text

Abstract:

Background/Objectives: Perioperative hypotension during kidney transplantation poses a risk to graft function and survival. Angiotensin II (AngII) is an endogenous vasoconstrictor targeting the renin–angiotensin–aldosterone system (RAAS) to increase blood pressure. Black patients may have a different response to synthetic angiotensin II (AT2S) compared to non-Black patients, given differential expressions in renin profiles. The purpose of this study is to assess the difference between Black and non-Black patients in total vasopressor duration and usage when AT2S is first line for hypotension d

APA, Harvard, Vancouver, ISO, and other styles

50

Asher, Elad, Hani Karameh, Hamed Nassar, et al. "Safety and Outcomes of Peripherally Administered Vasopressor Infusion in Patients Admitted with Shock to an Intensive Cardiac Care Unit—A Single-Center Prospective Study." Journal of Clinical Medicine 12, no. 17 (2023): 5734. http://dx.doi.org/10.3390/jcm12175734.

Full text

Abstract:

Background: Vasopressors are frequently utilized for blood pressure stabilization in patients with cardiogenic shock (CS), although with a questionable benefit. Obtaining central venous access is time consuming and may be associated with serious complications. Hence, we thought to evaluate whether the administration of vasopressors through a peripheral venous catheter (PVC) is a safe and effective alternative for the management of patients with CS presenting to the intensive cardiovascular care unit (ICCU). Methods: A prospective single-center study was conducted to compare the safety and outc

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!